日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors

一项针对晚期实体肿瘤患者持续口服 OSI-906(胰岛素样生长因子 1 和胰岛素受体的双重抑制剂)的 I 期研究

Igor Puzanov, Colin R Lindsay, Laura Goff, Jeff Sosman, Jill Gilbert, Jordan Berlin, Srinivasu Poondru, Ronit Simantov, Rich Gedrich, Andrew Stephens, Emily Chan, T R Jeffry Evans

Equitable access to developmental surveillance and early intervention--understanding the barriers for children from culturally and linguistically diverse (CALD) backgrounds

公平地获得发育监测和早期干预——了解来自文化和语言多元化(CALD)背景的儿童所面临的障碍

Woolfenden, Susan; Posada, Natalie; Krchnakova, Renata; Crawford, Jill; Gilbert, John; Jursik, Bronwynn; Sarkozy, Vanessa; Perkins, Deborah; Kemp, Lynn

Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer

奥沙利铂和培美曲塞作为局部晚期头颈癌诱导治疗方案的 2 期临床试验

Jill Gilbert, Barbara Murphy, Mary S Dietrich, Eve Henry, Richard Jordan, Ashley Counsell, Pamela Wirth, Wendell G Yarbrough, Robert J Slebos, Christine H Chung

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

肺癌中髓系抑制细胞中的精氨酸酶 I 由 COX-2 诱导

Paulo C Rodriguez, Claudia P Hernandez, David Quiceno, Steven M Dubinett, Jovanny Zabaleta, Juan B Ochoa, Jill Gilbert, Augusto C Ochoa